Biotech takeover target Abivax sinks over 30% as cancer cases cloud trial data for bowel disease drug

Jun 2, 2026 - 06:35

0 0

Biotech takeover target Abivax sinks over 30% as cancer cases cloud trial data for bowel disease drug

A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

China imposes trade curbs on dozens of U.S. firms in retaliation for Pentagon blacklist

China imposes trade curbs on dozens of U.S. firms in re...

Jun 21, 2026 0 0

Pixar's 'Toy Story 5' lassos biggest opening weekend in franchise history with $160 million haul

Pixar's 'Toy Story 5' lassos biggest opening weekend in...

Jun 21, 2026 0 0

Meet Silverwood, the multigenerational housing community in California's Inland Empire

Meet Silverwood, the multigenerational housing communit...

Jun 22, 2026 0 0

Oil rises after Trump threatens fresh strikes on Iran, overshadowing peace talks

Oil rises after Trump threatens fresh strikes on Iran, ...

Jun 21, 2026 0 0

My teenage son is using AI to do his math homework. I'm now helping his school write its first AI policy.

My teenage son is using AI to do his math homework. I'm...

Jun 21, 2026 0 0

Here are all the new dragonriders in 'House of the Dragon,' including the girl who claimed Sheepstealer

Here are all the new dragonriders in 'House of the Drag...

Jun 21, 2026 0 0